Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, GA
Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, GA.
Diabetes Care. 2019 Jan;42(1):77-84. doi: 10.2337/dc18-1078. Epub 2018 Nov 19.
To examine changes in diabetes-related preventable hospitalization costs and to determine the contribution of each underlying factor to these changes.
We used data from the 2001-2014 U.S. National (Nationwide) Inpatient Sample (NIS) for adults (≥18 years old) to estimate the trends in hospitalization costs (2014 USD) in total and by condition (short-term complications, long-term complications, uncontrolled diabetes, and lower-extremity amputation). Using regression and growth models, we estimated the relative contribution of following underlying factors: total number of hospitalizations, rate of hospitalization, the number of people with diabetes, mean cost per admission, length of stay, and cost per day.
During 2001-2014, the estimated total cost of diabetes-related preventable hospitalizations increased annually by 1.6% (92.9 million USD; < 0.001). Of this 1.6% increase, 75% (1.2%) was due to the increase in the number of hospitalizations, which is a result of a 3.8% increase in diabetes population and a 2.6% decrease in the hospitalization rate, and 25% (0.4%) was due to the increase in cost per admission, for a net result of a 1.6% increase in cost per day and a 1.3% decline in mean length of stay. By component, the cost of short-term complications, lower-extremity amputations, and long-term complications increased annually by 4.2, 1.9, and 1.5%, respectively, while the cost of uncontrolled diabetes declined annually by 2.6%.
The total cost of diabetes-related preventable hospitalizations had been increasing during 2001-2014, mainly resulting from increases in number of people with diabetes and cost per hospitalization day. The underlying factors identified in our study could lead to efforts that may lower future hospitalization costs.
研究与糖尿病相关的可预防住院费用的变化,并确定每个潜在因素对这些变化的贡献。
我们使用了 2001 年至 2014 年美国全国(全国)住院患者样本(NIS)的数据,对成年人(≥18 岁)的住院费用(2014 年美元)的趋势进行了估计,这些费用按条件(短期并发症、长期并发症、未控制的糖尿病和下肢截肢)进行分类。我们使用回归和增长模型,估计了以下潜在因素的相对贡献:住院总人数、住院率、糖尿病患者人数、每次入院的平均费用、住院时间和每天的费用。
在 2001 年至 2014 年期间,与糖尿病相关的可预防住院费用的估计总成本每年增加 1.6%(9290 万美元;<0.001)。在这 1.6%的增长中,75%(1.2%)是由于住院人数的增加,这是由于糖尿病患者人数增加了 3.8%,住院率下降了 2.6%,25%(0.4%)是由于每次住院费用的增加,导致每天费用增加 1.6%,平均住院时间减少 1.3%。按组成部分计算,短期并发症、下肢截肢和长期并发症的费用分别以每年 4.2%、1.9%和 1.5%的速度增长,而未控制的糖尿病的费用则以每年 2.6%的速度下降。
2001 年至 2014 年期间,与糖尿病相关的可预防住院费用一直在增加,主要原因是糖尿病患者人数和每天住院费用的增加。我们在研究中确定的潜在因素可能会导致未来降低住院费用的努力。